Skip Nav Destination
Article navigation
Meeting Abstracts|
September 1980
Reduction of Fluorescent Myocardial Ischemia by Lidocaine
From the Departments of Cardiology and Anesthesiology, Mayo Clinic, Rochester, Minnesota 55901. Supported in part by Grant HL 12997.
Anesthesiology September 1980, Vol. 53, S124.
Citation
D. W. Baron, C. E. Harrison, R. E. Anderson, J. T. Walls, M. Sunamori, J. H. Tinker; Reduction of Fluorescent Myocardial Ischemia by Lidocaine. Anesthesiology 1980; 53:S124 doi: https://doi.org/10.1097/00000542-198009001-00124
Download citation file:
119
Views
Citing articles via
Most Viewed
Related Articles
Lidocaine and Mexiletine Inhibit Mitochondrial Oxidation in Rat Ventricular Myocytes
Anesthesiology (September 2001)
Sevoflurane Preconditioning before Moderate Hypothermic Ischemia Protects against Cytosolic [Ca 2+ ] Loading and Myocardial Damage in Part via Mitochondrial K ATP Channels
Anesthesiology (October 2002)
Lidocaine Protects from Myocardial Damage due to Ischemia and Reperfusion in Mice by Its Antiapoptotic Effects
Anesthesiology (May 2009)
Sevoflurane before or after Ischemia Improves Contractile and Metabolic Function while Reducing Myoplasmic Ca 2+ Loading in Intact Hearts
Anesthesiology (January 2002)
Cardioprotection during Diabetes: The Role of Mitochondrial DNA
Anesthesiology (April 2014)
